4//SEC Filing
IDENIX PHARMACEUTICALS INC 4
Accession 0001140361-14-031955
CIK 0001093649operating
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 5:11 PM ET
Size
10.2 KB
Accession
0001140361-14-031955
Insider Transaction Report
Form 4
SAK CORP
10% Owner
Transactions
- Other
Common Stock
2014-08-05$24.50/sh−53,331,109$1,306,612,171→ 0 total(indirect: See Footnote)
BAUPOST GROUP LLC/MA
10% Owner
Transactions
- Other
Common Stock
2014-08-05$24.50/sh−53,331,109$1,306,612,171→ 0 total(indirect: See Footnote)
KLARMAN SETH A
10% Owner
Transactions
- Other
Common Stock
2014-08-05$24.50/sh−53,331,109$1,306,612,171→ 0 total(indirect: See Footnote)
Footnotes (3)
- [F1]On August 5, 2014, Imperial Blue Corporation, a Delaware corporation ("Purchaser") and a wholly-owned subsidiary of Merck & Co., Inc., a New Jersey corporation ("Parent") merged with and into Idenix Pharmaceuticals, Inc., a Delaware corporation ("Idenix"), without a meeting of the stockholders of Idenix in accordance with Section 251(h) of the General Corporation Law of the State of Delaware, with Idenix continuing as the surviving corporation and thereby becoming a wholly-owned subsidiary of Parent.
- [F2]Each outstanding share of Idenix common stock, par value $0.001 per share (the "Shares") (other than Shares held (i) in the treasury of Idenix or by Parent, Purchaser or any of Parent's other subsidiaries, which Shares were canceled and ceased to exist or (ii) by stockholders who validly exercised appraisal rights under Delaware law with respect to such Shares), including the Shares reported above, were automatically canceled and converted into the right to receive $24.50 per Share, without interest, but subject to any required withholding of taxes.
- [F3]This statement on Form 4 is being jointly filed by The Baupost Group, L.L.C. ("Baupost"), SAK Corporation and Seth A. Klarman. Baupost is a registered investment adviser and acts as an investment adviser and general partner to certain private investment limited partnerships. SAK Corporation is the manager of Baupost. Mr. Klarman, as the sole director and sole officer of SAK Corporation and a controlling person of Baupost, may be deemed to have beneficial ownership under Section 13 of the Securities Exchange Act of 1934 of the securities beneficially owned by Baupost. Securities reported on this Form 4 as being beneficially owned by Baupost include securities purchased on behalf of various private investment limited partnerships. The reporting persons disclaim beneficial ownership of the securities except to the extent of their pecuniary interest therein.
Documents
Issuer
IDENIX PHARMACEUTICALS INC
CIK 0001093649
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001093649
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 5:11 PM ET
- Size
- 10.2 KB